[Federal Register Volume 80, Number 82 (Wednesday, April 29, 2015)]
[Notices]
[Page 23805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09875]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevent ToxPharm.
    Date: May 19, 2015.
    Time: 10:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas M. Vollberg, Ph.D., Chief, Scientific 
Review Officer, Research Technology and Contract Review Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240-276-
6341, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Novel Imaging Agents to Expand the Clinical Toolkit for 
Cancer Diagnosis, Staging and Treatment.
    Date: May 20, 2015.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20850, 240-276-6373, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevent Bioefficacy/Intermediate Endpoints.
    Date: May 28, 2015.
    Time: 10:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas M. Vollberg, Ph.D., Chief, Scientific 
Review Officer, Research Technology and Contract Review Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240-276-
6341, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Tumor Tissue Culture Systems.
    Date: June 23, 2015.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposal.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 6W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Rockville, MD 20850, 240-276-6374, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Omnibus SEP-16.
    Date: July 15, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 6W032, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W120, Rockville, MD 20850, 240-276-6457, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 23, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-09875 Filed 4-28-15; 8:45 am]
 BILLING CODE 4140-01-P